Doctor Addictions

Edit

Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Joplin Globe 05 Dec 2023

The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... .

Edit

The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Sharon Herald 05 Dec 2023

The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... ....

Edit

The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake

The Virginian-Pilot 05 Dec 2023

By Associated Press . ap@dfmdev.com. PUBLISHED. December 4, 2023 at 12.02 a.m. UPDATED ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... ___ ... .

Edit

Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake

New York Post 05 Dec 2023

Why Dems alienate working class, Sandra Day O’Connor, RIP and other commentary ... 4, 2023, in Washington. AP ... AP. OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... ....

Edit

Supreme Court wrestles with OxyContin maker's bankruptcy deal, billions of dollars at stake

The Day 05 Dec 2023

The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... Close.

Edit

As high court weighs Purdue bankruptcy, opioid settlement divides victims

The Keene Sentinel 04 Dec 2023

State governments and others suing Purdue allege that the public health crisis was fueled in part by the company’s aggressive marketing to doctors of OxyContin — which was introduced in the mid-1990s — even as evidence mounted that the drug was highly addictive.

Edit

J&K records 6306 HIV cases in 25-years; HIV prevalence in UT lowest in the country

Deccan Herald 04 Dec 2023

So, it is very important to stop drug abuse in Kashmir,” doctors said and added that due to social stigma, many people aren’t coming forward for HIV tests.</p><p>As per doctors’ drug addicts are at a higher risk of contracting HIV/AIDS and if they are sexually active, ...

Edit

US Supreme Court to scrutinize controversial opioid crisis settlement that would give Sackler family immunity

CNN 04 Dec 2023

The company – and its founders – have been accused of helping to fuel the opioid epidemic in the United States by aggressively marketing the drug as safer and less addictive, encouraging doctors to prescribe the drug over longer periods of time.

Edit

OxyContin maker's bankruptcy deal goes before the Supreme Court, with billions of dollars at stake

Statesville Record & Landmark 04 Dec 2023

Harmony physician remembered as country doctor ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers.

Edit

OxyContin maker bankruptcy deal goes before the Supreme Court on Monday, with billions at stake

Times Union 04 Dec 2023

Arguments take place Monday ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of the powerful prescription painkiller is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... A decision in Harrington v ... .

Edit

OxyContin maker’s bankruptcy deal goes before the Supreme Court, with billions of dollars at stake

Sun Sentinel 04 Dec 2023

By MARK SHERMAN (Associated Press) ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... Most of those are from fentanyl and other synthetic drugs ... ___ ... ....

Edit

Supreme Court to hear Purdue Pharma settlement case that shields Sackler family

NBC Bay Area 04 Dec 2023

Get a weekly recap of the latest San Francisco Bay Area housing news ... The U.S ... Opioid Crisis Nov 23 ... OxyContin Jun 21 ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... .

Edit

Supreme Court Wrestles With OxyContin Maker's Bankruptcy Deal

Voa News 04 Dec 2023

But later, Kagan also said that in bankruptcies, protection against lawsuits has a price.� ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma's aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers.� ... .

Edit

SCOTUS set to hear arguments over $6BILLION nationwide settlement with OxyContin maker Purdue Pharma...

The Daily Mail 04 Dec 2023

This payment amounts to half the Sackler family's collective fortune, much of it held offshore ... (Pictured ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma´s aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... .

Edit

U.S. Supreme Court to review settlement with Purdue Pharma over opioids

Cleveland 04 Dec 2023

Arguments take place Monday ... The U.S ... OxyContin first hit the market in 1996, and Purdue Pharma’s aggressive marketing of the powerful prescription painkiller is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers ... A decision in Harrington v ... Footer Navigation.

Doctor

Personal titles

Fictional characters

Film and television

First Doctor

Dr. Who (Dalek films)

Personality

Podcasts:

Latest News for: Doctor addictions

Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake

Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake

Supreme Court wrestles with OxyContin maker's bankruptcy deal, billions of dollars at stake

As high court weighs Purdue bankruptcy, opioid settlement divides victims

J&K records 6306 HIV cases in 25-years; HIV prevalence in UT lowest in the country

US Supreme Court to scrutinize controversial opioid crisis settlement that would give Sackler family immunity

OxyContin maker's bankruptcy deal goes before the Supreme Court, with billions of dollars at stake

OxyContin maker bankruptcy deal goes before the Supreme Court on Monday, with billions at stake

OxyContin maker’s bankruptcy deal goes before the Supreme Court, with billions of dollars at stake

Supreme Court to hear Purdue Pharma settlement case that shields Sackler family

Supreme Court Wrestles With OxyContin Maker's Bankruptcy Deal

SCOTUS set to hear arguments over $6BILLION nationwide settlement with OxyContin maker Purdue Pharma...

U.S. Supreme Court to review settlement with Purdue Pharma over opioids

Article Search

Most Viewed

EXPLORE WN.com